Subscribe
Sign in
Home
Notes
Idea Archive
Portfolio
Philosophy
Disclaimer
About
Latest
Top
Discussions
A Microcap At Its Earnings Inflection (With Free Defense Optionality)
Profitable, insider-aligned, debt-free, and quietly compounding a recurring revenue tail behind every device sold.
Jul 6
•
Schwar Capital Research
4
1
June 2026
My Top 25 Investing Books
25 books on risk, compounding, and thinking clearly under uncertainty.
Jun 22
•
Schwar Capital Research
23
NEW POSITION: A Rare Disease Compounder
A US-listed portfolio position, executing ahead of plan, with a freshly raised long-term vision.
Jun 19
•
Schwar Capital Research
3
1
The Pyramid: How I Actually Build a Portfolio
A companion piece to this month's portfolio update. The trades only make sense if you understand the structure they serve - so here's my structure…
Jun 15
•
Schwar Capital Research
6
June Portfolio Update: One Out, Three In
A busier month than usual. One position closed, two added to, and three brand-new names entering the book.
Jun 12
•
Schwar Capital Research
3
1
CeoTronics Update: Three Records, One Caveat
Preliminary FY2025/26 print
Jun 8
•
Schwar Capital Research
6
1
1
The Case for Simplicity: What Taleb and Mandelbrot Taught Me About Surviving Markets
Why the most sophisticated investors often use the simplest strategies - and why complexity is usually just risk in disguise.
Jun 5
•
Schwar Capital Research
12
2
A Speculative Bet I'm Seriously Considering
A Canadian microcap is being rebuilt in plain sight. Speculative, asymmetric, and possibly heading into the portfolio.
Jun 1
•
Schwar Capital Research
5
1
1
May 2026
Spectra Systems: First Follow-On Sensor Order Lands
The optionality starts converting.
May 28
•
Schwar Capital Research
7
1
TruFin Sells Playstack: The Catalyst Fired, and Why I'm Selling (TRU.L)
£125m for Playstack, a proposed £70m return at 140p, and a stub I don't have an edge in. The endgame I kept flagging has arrived. The thesis didn't…
May 25
•
Schwar Capital Research
4
The Five Taleb Lessons That Shape Schwar Capital
Investing in a world you cannot predict
May 18
•
Schwar Capital Research
20
1
KFS Q1 2026: The J-Curve Has Turned.
Adjusted EBITDA up 78%, KSX at record profitability, every business firing at once. And there is a quiet re-rating catalyst nobody is pricing in.
May 15
•
Schwar Capital Research
6
2
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
